TABLE 2.
Participant demographics by intervention vs control group
| Intervention | Control | |
|---|---|---|
| Characteristic | n = 29 | n = 29 |
| X (SD) | X (SD) | |
| Age (years) | 59 (10) | 57 (12) |
| Months since cancer-related surgery* | 30 (24)* | 44 (29)* |
| Months since chemotherapy* n = 28 | 22 (12)* | 51 (26)* |
| Months since radiation n = 46 | 26 (25) | 40 (28) |
| Number of days Fitbit was not worn in the study (participants whose Fitbit data were accessible n = 35) | 26 (12) | 33 (16) |
| Height (inches) | 63.10 (2.45) | 63.83 (2.75) |
| Weight (pounds) | 175 (36) | 181 (43) |
| N (%) | N (%) | |
| Race* | ||
| African American or Black | 11 (19)* | 4 (7)* |
| White or Caucasian | 18 (31)* | 25 (43)* |
| Employment | ||
| Unemployed | 2 (6.8) | 0 (0) |
| Work part time | 4 (13.7) | 1 (3.4) |
| Work full time | 10 (34.4) | 14 (48.2) |
| Retired | 11 (37.9) | 12 (41.3) |
| Homemaker | 1 (3.4) | 1 (3.4) |
| Other | 1 (3.4) | 1 (3.4) |
| Marital status | ||
| Single, never married | 3 (10.3) | 3 (10.3) |
| Intervention | Control | |
| Characteristic | n = 29 | n = 29 |
| Married or domestic partnership | 17 (58.6) | 23 (79.3) |
| Widowed | 3 (10.3) | 1 (3.4) |
| Divorced/separated | 6 (20.5) | 2 (6.8) |
| Health insurance | 28 (97) | 29 (100) |
| Cancer stage | ||
| Ia | 14 (48.2) | 11 (37.9) |
| Ib | 1 (3.4) | 2 (6.8) |
| IIa | 10 (34.4) | 11 (37.9) |
| IIb | 4 (13.7) | 5 (17.2) |
| Surgery type | ||
| Mastectomy | 10 (34.4) | 9 (31) |
| Partial mastectomy | 0(0) | 4 (13.7) |
| Lumpectomy | 21 (72.4) | 16 (55.1) |
| Taking aromatase inhibitors | ||
| Arimidex (anastrozole) | 8 (27.5) | 4 (13.7) |
| Aromasin (exemestane) | 1 (3.4) | 1 (3.4) |
| Femera (letrozole) | 3 (10.3) | 5 (17.2) |
| Taking selective estrogen receptor modulator | 6 (20.6) | 13 (44.8) |
| Wore Fitbit prior to study | 6 (20.6) | 12 (41.3) |
| Able to obtain Fitbit data | 17 (58.62) | 18 (41.38) |
*
P < .05.